A Randomized, Blind, Placebo-controlled, Single-centre Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of AZD7687 After Single Ascending Oral Doses.

Trial Profile

A Randomized, Blind, Placebo-controlled, Single-centre Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of AZD7687 After Single Ascending Oral Doses.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Feb 2013

At a glance

  • Drugs AZD 7687 (Primary)
  • Indications Obesity; Type 2 diabetes mellitus
  • Focus Adverse reactions; Biomarker; Pharmacogenomic
  • Sponsors AstraZeneca
  • Most Recent Events

    • 22 Jun 2010 Actual end date added to 1 Jun 2010 as reported by ClinicalTrials.gov.
    • 22 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jan 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top